Epigenetics.
Epigenetics
C. David Allis, Thomas Jenuwein, & Danny Reinberg, editors
Cold Spring Harbor Laboratory Press
500 Sunnyside Boulevard, Woodbury, NY 11797-2924
0879697245 $150.00 www.cshlpress.com
Epigenetics is a scientific textbook written to teach
In addition, make sure to read these articles:
- C. David Allis to Receive the Third Annual Wiley Prize in the Biomedical Sciences.
- The Wiley Foundation Announces Recipients of the Fifth Annual Wiley Prize in Biomedical...
- John Wiley & Sons, Inc., Reports Solid Revenue and EPS Growth for the Third Quarter.
- Boston Probes Inc. Licenses PNA Technology to Human Genetic Signatures.
- Five new medical/biology titles from Landes Bioscience.
- Market profile: ChIP chips.
- MGI PHARMA And MethylGene Announce Data Presented At 2001 AACR-Sponsored Epigenetics of...
- Methylgene Inc. Publishes Scientific Results on 2 Novel Cancer Targets; DNA...
- Shattered body shattered self
- PrimeGen Biotech Announces First Data Successfully Showing the Derivation of Human Heart,...
- SensiGen Options Epigenetic Biomarkers for Early Detection and Monitoring of Lupus.
- PrimeGen Biotech Successfully Derives Human Heart, Brain, Bone and Cartilage Cells from...
- MethylGene Reports Scientific Progress in Two Anticancer Programs - DNA Methyltransferase...
- Cenix BioScience and CellCentric Sign Framework Research Agreement for RNAi-Based Target...
- MGI PHARMA Reports 2001 Third Quarter Results; Both Phase 3 Programs Continue to Progress.
Business Editors/Science Writers/Health/Medical Writers HOBOKEN, N.J.--(BUSINESS WIRE)--Jan. 27, 2004 Deborah E. Wiley, Chairman of The Wiley Foundation, and Senior Vice President, John Wiley & Sons, ......
HOBOKEN, N.J. -- Deborah E. Wiley, Chairman of The Wiley Foundation, and Senior Vice President, John Wiley & Sons, Inc., announced today that the ......
Business Editors HOBOKEN, N.J.--(BUSINESS WIRE)--March 2, 2004 John Wiley & Sons, Inc. (NYSE:JWa) (NYSE:JWb), announced today that revenue for the third quarter increased 10%, or ......
Business Editors & Health/Medical Writers BEDFORD, Mass. & SYDNEY, Australia--(BW HealthWire)--June 25, 2001 Boston Probes announced today that it has entered into a development and ......
Biology and medical publisher Landes Bioscience (Georgetown, TX) has begun the publication of two new journals, including "Autophagy" and ""Human Vaccines," and will launch three ......
Epigenetics, which is the study of different factors that influence gene regulation, has become one of the hottest applications in genomic research. Basically, researchers ......
Business Editors & Health/Medical Writers MINNEAPOLIS & MONTREAL--(BUSINESS WIRE)--Oct. 18, 2001 Data Further Validates DNA Methyltransferase as a Novel Cancer Target in the field of ......
Business & Health/Medical Editors BIOWIRE2K MONTREAL--(BW HealthWire)--Aug. 6, 2002 MethylGene Inc., a Canadian drug discovery and development company, publishes scientific results on two of its ......
Is the genome a computer? Not, "is the genome, in the way it is constructed and in the way it functions, analogous to the way ......
IRVINE, Calif. -- In a breakthrough for stem cell research and cellular replacement therapies, PrimeGen Biotech LLC (www.primegenbiotech.com) today announced that this week, its ......
ANN ARBOR, Mich. & PHILADELPHIA -- SensiGen LLC, a biotechnology company developing advanced gene-based molecular diagnostics, announced today that it has acquired an option from ......
IRVINE, Calif. -- PrimeGen Biotech LLC: --PrimeCell(TM) -- First Human Adult Stem Cell Showing Ability to Differentiate into Any Cell in the Body -- ......
Business Editors/Health/Medical Writers BIOWIRE2K MONTREAL--(BUSINESS WIRE)--Jan. 8, 2003 MethylGene Inc., a private Canadian drug discovery and development company, discloses new scientific data on its cancer ......
DRESDEN, Germany -- Cenix BioScience GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, today announced that it has signed a framework ......
Business Editors & Health/Medical Writers MINNEAPOLIS--(BUSINESS WIRE)--Oct. 17, 2001 MGI PHARMA, INC., (Nasdaq:MOGN) today reported total revenues of $6.9 million in the quarter ended September ......
Email
Digg It
del.icio.us
Business Resources
Sponsored Links
Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy
Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.
© Copyright 2008 The Gale Group, Inc. All rights reserved.
© COPYRIGHT 2007 Midwest Book Review
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
© COPYRIGHT 2007 Midwest Book Review
You may not repost, republish, reproduce, package and/or redistribute the content of this page,
in whole or in part, without the written permission of the copyright holder.
Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.
AllBusiness.com, its parent company D&B, and its affiliates.
